Fundraising FoxFibrogen
San Francisco, US · 5 known investors
Find your way into Fibrogen
Sign up to find every way you can get introduced to Fibrogen
- Your email: who you already know at Fibrogen, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Fibrogen team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions. Its pipeline includes drug candidates such as roxadustat and FG-3246.
Founders & leadership
Board
Investors · 5
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: Ridgeback Capital's portfolio page · Not right? Tell us
How we know: Scientia Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20M disclosed across 1 round · 2014
▶$20MraisedDec 2014 · 1 investors · PharmaceuticalsRule 506(b)
- Frank H. ValoneExecutive Officer
- Thomas F. KearnsDirector
- K. Peony YuExecutive Officer
- Jorma RouttiDirector
- Miguel MaderoDirector
- Rory B. RiggsDirector
- Toshinari TamuraDirector
- Kalevi KurkijarviDirector
- Julian N. SternDirector
- Thomas B. NeffExecutive Officer, Director
- James A. SchoeneckDirector
- Pat CotroneoExecutive Officer
- Roberto Pedro RosenkranzDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Fibrogen went on to found or lead other companies.
Frequently asked questions
- What does Fibrogen do?
- Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions. Its pipeline includes drug candidates such as roxadustat and FG-3246.
- Who founded Fibrogen?
- Fibrogen was founded by Thomas B. Neff.
- Who are Fibrogen's investors?
- Fibrogen's investors include Avalon BioVentures, Foresite Capital, Ridgeback Capital, Scientia Ventures, Maverick Ventures.
- How much funding has Fibrogen raised?
- Fibrogen has disclosed $20M raised across 1 round.
- Where is Fibrogen headquartered?
- Fibrogen is headquartered in San Francisco, US.